Elevated ApoB/apoA-1 is Associated with in-Hospital Mortality in Elderly Patients with Acute Myocardial Infarction

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Important Indicators for Predicting in-Hospital Death in Elderly AMI Patients

(2023) Yan Chen et al.   Journal of Inflammation Research

Elevated ApoB/ApoA-Ι ratio is associated with poor outcome in acute ischemic stroke

(2022) Zhizhang Li et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study

(2022) Tianyu Li et al.   Lipids in Health and Disease

Elevated Apolipoprotein B/A-1 Ratio is Associated With an Increased Risk of Aortic Stenosis: Experience From the AMORIS Cohort

(2021) Torbjörn Ivert et al.   Heart Lung and Circulation

Percutaneous coronary intervention during on- and off-hours in patients with ST-segment elevation myocardial infarction

(2021) Tomasz Tokarek et al.   Hellenic Journal of Cardiology

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

(2021) Henry N Ginsberg et al.   EUROPEAN HEART JOURNAL

The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients

(2021) Zhenjun Ji et al.   Frontiers in Cardiovascular Medicine

Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study

(2021) Göran Walldius et al.   PLOS MEDICINE

The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B

(2021) Richard J. Webb et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

(2020) Børge G. Nordestgaard et al.   ATHEROSCLEROSIS

Mortality rate in patients treated with percutaneous coronary interventions in acute mode is more prone to be affected by operator volume as elective interventions

(2020) Michał Zabojszcz et al.   Kardiologia Polska

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease

(2020) Edward K. Duran et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?

(2020) Michel R. Langlois et al.   Current Cardiology Reports

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2020) Jean-Philippe Collet et al.   EUROPEAN HEART JOURNAL

Prevalence and Predictors of Coronary Artery Perforation during Percutaneous Coronary Interventions (From the ORPKI National Registry in Poland)

(2019) Tomasz Rakowski et al.   AMERICAN JOURNAL OF CARDIOLOGY

apoB/apoA‐I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC‐Norfolk Prospective Population Study

(2019) Kang H. Zheng et al.   Journal of the American Heart Association

Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment

(2018) Stuart S. Carr et al.   PATHOLOGY

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography

(2015) Yongyan Song et al.   Lipids in Health and Disease

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

(2014) S. D. Kristensen et al.   EUROPEAN HEART JOURNAL

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

(2014) Frants Pedersen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation

(2013) Anette Varbo et al.   CIRCULATION

ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management

(2013) Tjerk de Nijs et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Population Trends in Percutaneous Coronary Intervention

(2013) Marieke L. Fokkema et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Anti-inflammatory effects of apolipoprotein A-I in the rabbit

(2010) Sanjay Patel et al.   ATHEROSCLEROSIS

The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls

(2009) S. Parish et al.   EUROPEAN HEART JOURNAL

Apo-B/apo-AI ratio: a better discriminator of coronary artery disease risk than other conventional lipid ratios in Indian patients with acute myocardial infarction

(2008) B. Goswani et al.   ACTA CARDIOLOGICA

Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

(2008) Matthew J McQueen et al.   LANCET